Nordicus Partners Corp. is a biotech company, which specializes in developing breakthrough therapeutics in diseases with unmet medical needs. It focuses on acquisition and development of drugs from innovative biotech companies in the Nordics. The company was founded on April 7, 1993 and is headquartered in Beverly Hills, CA.
Sector:
Process Industries
Industry:
Chemicals Specialty
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Nordicus Partners Corp market cap is $48.8M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nordicus Partners Corp 52 week high is $5.15 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nordicus Partners Corp 52 week low is $1.48 as of November 17, 2026.
Nordicus Partners Corp stock price today is $2.87.
Nordicus Partners Corp stock price yesterday was $2.51.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Nordicus Partners Corp's P/E ratio is -10.54.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Nordicus Partners Corp P/B ratio is 0.8935.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Nordicus Partners Corp 50-day moving average is $3.70.